Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Course Development Handbook Appendix 7 s Module specification template Title Code Level Credit rating Pre-requisites Type of module Aims Learning outcomes/objectives Content Comments/notes Parenteral Therapy CLM04 7 20 Graduate Registered Pharmacists The module is delivered within the workplace using the module material provided by the London, Eastern and South East Clinical Pharmacy Service. 1. To provide a comprehensive understanding of the equipment involved in the administration of parenteral solutions. 2. To critically evaluate the pharmacological and pharmaceutical characteristics of drugs to ensure compatability with common parenteral routes of administration. 3. To produce clinical pharmacists competent to advise on aspects of parenteral therapy. 4. To provide pharmacists with a comprehensive understanding of the risks associated with parenteral therapy and the skills required to manage these problems. On completion of this unit of study the participant should be able to: 1. Describe the role of health care workers in the prescribing, administration and monitoring of parenteral therapy, 2. To demonstrate a critical awareness of the current pharmacological, pharmaceutical and equipment knowledge and to apply this to rationalise the parenteral therapy of patients, 3. To demonstrate a comprehensive understanding of both drug and patient parameters as they apply to the selection of parenteral therapy. 4. To critically evaluate the patient’s response to the technology used, 5. To demonstrate competence when providing pharmaceutical care to patients receiving parenteral therapy, 6. To critically evaluate the safety and effectiveness of parenteral therapy in order to make sound judgments when providing advice to other health care professionals. Describe the different methods of parenteral drug administration, their limitations and the rationale for their selection. Acquire a sufficient understanding of the different types of equipment available to administer parenteral therapy in order to be able to offer advice in selecting a suitable device. 52 Course Development Handbook Appendix 7 Content (cont.) Teaching strategies and Learning support Assessment tasks Dosage calculations relating to any drug dosing or drug infusion administration commonly found in clinical practice and advise nursing and medical staff on the safe practice when mixing drugs and fluids in a bag, line or syringe. Make recommendations on the handling, storage and administration of parenteral drugs so that they remain safe and efficacious for their allocated shelf life. Discuss the provision of advice and information to healthcare staff involved in prescribing, preparing and administering parenteral therapy. Identify and describe the complications associated with parenterally administered drugs and advise on the strategies to prevent and treat these. Understand the risk management issues surrounding the administration of high risk drugs. Describe the benefits and the current level of CIVA services available. learning Details of the standard module format are provided in the programme specification. The material is presented in electronic form and is normally provided to the student to work through systematically under the supervision of an appropriate senior clinical practitioner. Periodic meetings with the local tutor allows understanding and the application of this information to patient care to be reviewed and the ability of the individual to perform key skills to be evaluated. Material is presented as a computer package to direct the student learning. Students are then required to complete an array of practice activities (see programme specification) and demonstrate their competence to perform an array of clinical tasks before being eligible to register for the module assessment. Students are required to read and evaluate articles contained within the appropriate medical journals in addition to the appropriate chapters contained within the general indicative texts listed below: Dougherty L and Lamb J. Intravenous Therapy in Nursing Practice. Churchill Livingstone 1999 Trissell LA. Handbook on Injectable Drugs.(11th Edition) American Society of Health-System Pharmacists. 2001. Allowed M, Stanley A & Wright P. The Cytotoxic Handbook. 4th Edition. Radcliffe Medical Press. 2001. The assessment strategy embraces the concept of “fitness for purpose” so that students are required to demonstrate their ability to apply the knowledge and skills acquired to resolve a range of clinical problems. This requires the student to gather and critically evaluate clinical data prior to engaging in complex decision making, culminating in the provision of advice to health care professionals and patients. These problems are designed to reflect scenarios routinely encountered in clinical practice. This requires students to complete an objective structured clinical examination (OSCE), comprising of 10 clinical scenarios, reflecting clinical practice in the module being studied. To pass the module students must satisfy the criteria in 7 of the ten stations, and present an acceptable portfolio. 53 Course Development Handbook Appendix 7 Brief description of module The module details the signs, symptoms and biochemical content and/or aims tests associated with patients who receive parenteral therapy. (maximum 80 words) A comprehensive, practice-based review of the available information follows. Students are required to apply this knowledge to resolve drug related problems in patients receiving drugs via the parenteral route. Area examination board to Course Examination Board only (normally March and September each year) which module relates Produced by practitioners with a special interest in Module team/authors/ parenteral therapy. Module leader – Jane Nichols(Associate coordinator Director, London, Eastern and SE Clinical Pharmacy Services) Semester offered, where Not applicable. appropriate The School of Pharmacy and Biomolecular Sciences of the Site where delivered university is responsible for the designing and organising the assessment process and the overall standard of the course. The local hospitals have responsibility for the tuition, which is co-ordinated by the London, Eastern and South East Clinical Pharmacy Service. August 1994 Date of first approval September 2004 Date of last revision Date of approval of this version 3 Version number Replacement for previous module Field for which module is acceptable and status in that field Course(s) for which module PG Certificate in Applied Therapeutics. PG Diploma in is acceptable and status in Clinical Pharmacy Practice. that course Pharmacy and Biomolecular Sciences School home Mr Jonathan Silcock. March 2004 - 2008 External examiner 54